BOCA RATON, Fla.--(BUSINESS WIRE)--Sept. 21, 2006--Nutra Pharma Corp. (OTCBB:NPHC), a biotechnology company that is developing drugs for HIV and Multiple Sclerosis, has announced that its holding, ReceptoPharm, has been invited to be a featured speaker at the 11th Annual Immunobiology Symposium in Tahoe City, California.
